Millions of lives around the world could be saved by increasing regional vaccine manufacturing capacity. The Regionalized Vaccine Manufacturing Collaborative (RVMC), incubated at the World Economic Forum in partnership with Deloitte and co-chaired by the U.S. National Academy of Medicine and the Coalition for Epidemic Preparedness Innovations (CEPI), will now be established as a Global Initiative hosted at CEPI. This new Global Initiative will begin with an initial CEPI commitment of $15 million and be led by partner organizations including the Africa CDC, CEPI, Pan-American Health Organization, U.S. National Academy of Medicine, and the World Economic Forum in collaboration with both public and private sector leaders across regions. Dr Frederik Kristensen, former Deputy CEO of CEPI will assume the newly created role of RVMC Director. In this new capacity, RVMC will offer convening, thought capital, advocacy, matchmaking, catalyzing, clearinghouse, and other technical support services directly to and across regional manufacturing initiatives to enable their success. … The output of this work is the eight-pillar RVMC Framework that enables regions to strategically assess where they are and how to navigate the technical, market and financial challenges of expanding vaccine manufacturing capacity in collaboration with the private sector.
World Economic Forum